共 154 条
[1]
Siegel RL(2020)Cancer statistics, 2020 CA Cancer J Clin. 70 7-30
[2]
Miller KD(2019)Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors World J Oncol. 10 10-27
[3]
Jemal A(2001)Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial Lancet 358 1576-1773
[4]
Rawla P(2007)Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 267-194
[5]
Sunkara T(2010)Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial JAMA 304 1073-2556
[6]
Gaduputi V(2008)Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial JAMA 299 1019-536
[7]
Neoptolemos JP(2018)FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer N Engl J Med 379 2395-533
[8]
Dunn JA(2020)Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial J Clin Oncol. 38 1763-784
[9]
Stocken DD(2019)Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05) Jpn J Clin Oncol. 49 190-486
[10]
Oettle H(2019)Neoadjuvant Therapy for Resectable Pancreatic Cancer: An Evolving Paradigm Shift Front Oncol. 9 1085-162